Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
91 results:

  • 1. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
    Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
    Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle.
    Li Y; Zhao D; Zhang W; Yang M; Wu Z; Shi W; Lan S; Guo Z; Yu H; Wu D
    J Transl Med; 2023 Jun; 21(1):422. PubMed ID: 37386467
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Donnelly M; Ryan OK; Ryan ÉJ; Creavin B; O'Reilly M; McDermott R; Kennelly R; Hanly A; Martin ST; Winter DC
    Br J Surg; 2023 Sep; 110(10):1316-1330. PubMed ID: 37330950
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Up-regulation of ABCG2 by mybL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer.
    Hui YJ; Chen H; Peng XC; Li LG; Di MJ; Liu H; Hu XH; Yang Y; Zhao KL; Li TF; Yu TT; Wang WX
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103558. PubMed ID: 37030434
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcription factor B-myb activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer.
    Liu F; Wang Y; Cao Y; Wu Z; Ma D; Cai J; Sha J; Chen Q
    Chem Biol Interact; 2023 Apr; 374():110412. PubMed ID: 36812959
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High Diversity of Glycosphingolipid Glycans of colorectal cancer Cell Lines Reflects the Cellular Differentiation Phenotype.
    Wang D; Madunić K; Zhang T; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
    Mol Cell Proteomics; 2022 Jun; 21(6):100239. PubMed ID: 35489554
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Elevated expression of the myb proto-oncogene like 2 (mybL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
    Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
    Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype.
    Sugai T; Osakabe M; Niinuma T; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H
    Genes Chromosomes Cancer; 2022 Mar; 61(3):161-171. PubMed ID: 34846081
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment response to eribulin and anlotinib in lung metastases from rare perianal adenoid cystic carcinoma: a case report.
    Zheng S; Li H; Lin Y; Xie Y; Yin Z; Ge W; Yu T
    Anticancer Drugs; 2022 Jan; 33(1):e548-e554. PubMed ID: 34321419
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. B-myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2.
    Fan X; Wang Y; Jiang T; Liu T; Jin Y; Du K; Niu Y; Zhang C; Liu Z; Lei Y; Bu Y
    Oncogene; 2021 Sep; 40(37):5613-5625. PubMed ID: 34316028
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. myb mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
    Sakuma K; Sasaki E; Hosoda W; Komori K; Shimizu Y; Yatabe Y; Aoki M
    Cancer Sci; 2021 Sep; 112(9):3846-3855. PubMed ID: 34286904
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Determination of the binding of natural products to the human c-myb oncogene promoter G-quadruplex DNA by capillary electrophoresis and electrospray ionization mass spectrometry].
    Wang S; Yang Y; Fan S; Li H; David DYC
    Se Pu; 2020 Sep; 38(9):1069-1077. PubMed ID: 34213273
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion.
    Kadioglu O; Saeed M; Mahmoud N; Azawi S; Mrasek K; Liehr T; Efferth T
    Arch Toxicol; 2021 Mar; 95(3):959-974. PubMed ID: 33515271
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated Bioinformatics Analysis Reveals Function and Regulatory Network of miR-200b-3p in Endometriosis.
    Hu W; Xie Q; Xu Y; Tang X; Zhao H
    Biomed Res Int; 2020; 2020():3962953. PubMed ID: 32802844
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [PARP10 Influences the Proliferation of colorectal Carcinoma Cells, a Preliminary Study].
    Wu CF; Xiao M; Wang YL; Threadgill MD; Li M; Tang Y; Lin X; Yang L; Li QS; Li X
    Mol Biol (Mosk); 2020; 54(2):252-261. PubMed ID: 32392194
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integrated Analysis of DNA Copy Number Changes and Gene Expression Identifies Key Genes in Gastric cancer.
    Feng Y; Shi C; Wang D; Wang X; Chen Z
    J Comput Biol; 2020 Jun; 27(6):877-887. PubMed ID: 31545074
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
    Beyes S; Andrieux G; Schrempp M; Aicher D; Wenzel J; Antón-García P; Boerries M; Hecht A
    Oncogene; 2019 Oct; 38(40):6647-6661. PubMed ID: 31391555
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. c-myb promotes growth and metastasis of colorectal cancer through c-fos-induced epithelial-mesenchymal transition.
    Qu X; Yan X; Kong C; Zhu Y; Li H; Pan D; Zhang X; Liu Y; Yin F; Qin H
    Cancer Sci; 2019 Oct; 110(10):3183-3196. PubMed ID: 31338937
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. miR‑675 promotes colorectal cancer cell growth dependent on tumor suppressor DMTF1.
    Yang X; Lou Y; Wang M; Liu C; Liu Y; Huang W
    Mol Med Rep; 2019 Mar; 19(3):1481-1490. PubMed ID: 30592263
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the Liver.
    Hass HG; Vogel U; Scheurlen M; Jobst J
    Oncology; 2018; 95(4):211-219. PubMed ID: 29920486
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.